[Development of bile acid therapy; from a choleretic to an immunomodulator, and at present time].
Makino
Isao
I
Second Department of Internal Medicine, Asahikawa Medical College.
D017209:Apoptosis; D001647:Bile Acids and Salts / Q000502:physiology; D000949:Histocompatibility Antigens Class II / Q000235:genetics; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D001647:Bile Acids and Salts; D000949:Histocompatibility Antigens Class II; D014580:Ursodeoxycholic Acid